1-3 of 3
Jenny L. Byrne, PhD
Close
Sort by
Journal Articles

Extracorporeal Photopheresis As Second Line Therapy for Steroid Refractory Acute Gvhd: Retrospective Study of Long-Term Outcomes

Rohini Radia, MBChB, Emma Das-Gupta, MD, Guillermo Orti, MD, Donal McLornan, MDPhD, Majid A. Kazmi, Christopher P Fox, PhD, Jenny L. Byrne, PhD, Nigel H. Russell, MD, Kavita Raj, MDPhD
Journal: Blood
Blood (2015) 126 (23): 1944.
https://doi.org/10.1182/blood.V126.23.1944.1944
Published: 2015
Journal Articles

Assessment of Quality of Life in the NCRI Spirit 2 Study Comparing Imatinib with Dasatinib in Patients with Newly-Diagnosed Chronic Phase Chronic Myeloid Leukaemia

Alexander M. Labeit, MDPhD, Mhairi Copland, BSc (Hons) MB ChB PhDFRCP FRCPath, Leanne M. Cork, BSc (Hons), Corinne A. Hedgley, BSc (Hons), Letizia Foroni, MDPhDFRCPath, Wendy L. Osborne, MBBS (Hons) MRCP FRCPath, Gemma Gills, MSc BSc (Hons), Jane F. Apperley, MD, Tessa L. Holyoake, MDPhD, Ruth V. Bescoby, MSc BSc, Christopher Pocock, Thomas Zwingers, MSc, Philippa Burnell, Jenny L. Byrne, PhD, John H. McCullough, John M. Goldman, DM FRCP FRCPath, Richard E. Clark, MD, Stephen G. O'Brien, BSc (Hons) PhD MBChB FRCP MRCPath
Journal: Blood
Blood (2015) 126 (23): 4024.
https://doi.org/10.1182/blood.V126.23.4024.4024
Published: 2015
Journal Articles

High Response Rate to DLI Based Strategies for the Treatment of Refractory Disease/Relapse Following Allogeneic HSCT for Lymphoproliferative Disease.

Nigel H. Russell, MD, Jenny L. Byrne, PhD, Emma P. Das-Gupta, MD, Michelle Gilyead, BSc, Andy P. Haynes, MD
Journal: Blood
Blood (2004) 104 (11): 1653.
https://doi.org/10.1182/blood.V104.11.1653.1653
Published: 2004